Pharmaceuticals

Gene Therapy Market Expansion Outlook: $31.48 Billion by 2029 Forecast

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Gene Therapy Market By 2029?

The gene therapy market has witnessed substantial expansion in recent years. Its valuation is anticipated to climb from $12.52 billion in 2024 to $16.36 billion in 2025, progressing at a compound annual growth rate (CAGR) of 30.7%. This historical upward trend can be ascribed to increased pharmaceutical research and development expenditure, a rise in public-private collaborations, government funding, and a growing incidence of spinal muscular atrophy.

The gene therapy market is anticipated to experience significant expansion over the coming years. Its valuation is projected to reach $31.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.8%. This anticipated market expansion during the forecast period is fueled by several factors, including the rising incidence of cancer, an expanding elderly demographic, increased expenditure on research and development within the pharmaceutical industry, and an enhanced emphasis on gene therapy. Key trends expected during this period involve improving business functions via obtaining regulatory clearances, bolstering business endeavors through strategic alliances and partnerships, broadening business capacities through strategic purchases, and fortifying operational strengths through business expansions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Factors And Drivers Are Influencing The Gene Therapy Market In 2025?

The notable rise in the occurrence of cancer and other target diseases necessitates effective treatments, thereby fueling the expansion of the gene therapy market. This global increase in cancer diagnoses is projected to bolster the gene therapy market’s growth throughout the forecast period. As an illustration, the American Cancer Society reported in January 2022 that the US is expected to see approximately 1.9 million new cancer diagnoses and 609,360 cancer-related deaths, translating to roughly 1,670 daily fatalities. Globally, lung, prostate, bowel, and female breast cancer represent the four most prevalent forms, collectively responsible for 43 percent of all newly identified cancer cases. Consequently, the escalating global cancer incidence rate is expected to significantly increase the demand for the gene therapy market in the coming years. Within oncology, gene therapy stands out as a highly effective treatment option, which involves inserting new genes into cancerous cells or adjacent tissues to either induce cell death or impede cancer progression.

How Is The Gene Therapy Market Segmented?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Which Key Trends Are Expected To Influence The Gene Therapy Market In The Coming Years?

The adoption of machine learning and artificial intelligence is progressively increasing within the gene therapy market. Artificial intelligence (AI) involves machines simulating human intelligence, programmed to exhibit their inherent capabilities. Machine learning constitutes a subset of AI. Both machine learning and AI empower companies in the gene therapy sector to conduct comprehensive analyses of relevant data, identify interactions between tumor and immune cells, and provide more accurate evaluations of tissue samples, an aspect frequently debated among different evaluators. For example, in May 2023, Form Bio, a US-based software company focused on life sciences, introduced FORMsightAI, a new AI-driven solution set for predicting and optimizing the manufacturing outputs of cell and gene therapy constructs. This comprehensive solution integrates advanced, adaptable AI models with Form Bio’s foundational platform and a skilled team of computational life sciences experts with backgrounds in biology, bioinformatics, and data science. FORMsightAI addresses common challenges faced by cell and gene therapy developers, including construct truncations and manufacturing contaminations, which are primary contributors to unacceptably low manufacturing yields, extended timelines to market, and therapeutic safety issues.

Which Leading Companies Dominate The Gene Therapy Market Share?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Does The Gene Therapy Market Perform Across Key Geographic Regions?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Gene Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795